These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11079578)

  • 1. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
    Dietrich G; Spreng S; Gentschev I; Goebel W
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated salmonella and Shigella as carriers for DNA vaccines.
    Xu F; Ulmer JB
    J Drug Target; 2003; 11(8-10):481-8. PubMed ID: 15203916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D; Weidinger G; Spreng S
    Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant attenuated bacteria for the delivery of subunit vaccines.
    Gentschev I; Dietrich G; Spreng S; Kolb-Mäurer A; Brinkmann V; Grode L; Hess J; Kaufmann SH; Goebel W
    Vaccine; 2001 Mar; 19(17-19):2621-8. PubMed ID: 11257401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.
    Dietrich G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):177-82. PubMed ID: 10912622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines.
    Dietrich G; Kolb-Mäurer A; Spreng S; Schartl M; Goebel W; Gentschev I
    Vaccine; 2001 Mar; 19(17-19):2506-12. PubMed ID: 11257384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances with recombinant bacterial vaccine vectors.
    Shata MT; Stevceva L; Agwale S; Lewis GK; Hone DM
    Mol Med Today; 2000 Feb; 6(2):66-71. PubMed ID: 10652479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial carriers and virus-like-particles as antigen delivery devices: role of dendritic cells in antigen presentation.
    Beyer T; Herrmann M; Reiser C; Bertling W; Hess J
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):287-302. PubMed ID: 12455402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells.
    Weiss S; Krusch S
    Biol Chem; 2001 Apr; 382(4):533-41. PubMed ID: 11405218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of bacterial vector technology.
    Kochi SK; Killeen KP; Ryan US
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of protein antigens and DNA by attenuated intracellular bacteria.
    Gentschev I; Dietrich G; Spreng S; Pilgrim S; Stritzker J; Kolb-Mäurer A; Goebel W
    Int J Med Microbiol; 2002 Feb; 291(6-7):577-82. PubMed ID: 11890559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bacterial systems for the delivery of recombinant protein or DNA.
    Spreng S; Dietrich G; Niewiesk S; ter Meulen V; Gentschev I; Goebel W
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):299-304. PubMed ID: 10727885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of DNA vaccines by attenuated intracellular bacteria.
    Dietrich G; Gentschev I; Hess J; Ulmer JB; Kaufmann SH; Goebel W
    Immunol Today; 1999 Jun; 20(6):251-3. PubMed ID: 10354548
    [No Abstract]   [Full Text] [Related]  

  • 16. Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.
    Shahabi V; Maciag PC; Rivera S; Wallecha A
    Bioeng Bugs; 2010; 1(4):235-43. PubMed ID: 21327055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turning self-destructing Salmonella into a universal DNA vaccine delivery platform.
    Kong W; Brovold M; Koeneman BA; Clark-Curtiss J; Curtiss R
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19414-9. PubMed ID: 23129620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent DNA-based vectors for DNA vaccine delivery.
    Roh YH; Lee K; Ye JJ; Luo D
    Methods Mol Biol; 2014; 1143():159-79. PubMed ID: 24715288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the development of live, attenuated bacterial vectors.
    Roland KL; Tinge SA; Killeen KP; Kochi SK
    Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.